{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-23-000729","form_type":"8-K","ticker":"USNA","cik":"0000896264","company_name":"USANA HEALTH SCIENCES INC","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.709124+00:00","generated_at":"2026-06-15T23:49:30.345636+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"USANA Health Sciences to enter India in Q3 2023, first new market in 5 years","bullets":["Expansion into India expected near end of Q3 2023; first new market in five years.","India launch increases USANA's global footprint to 25 markets.","FY2023 net sales and diluted EPS guidance (issued April 25) already reflects India's modest contribution.","President Jim Brown cites extensive research and preparation for the launch."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-23-000729","json":"https://secwatch.observer/filing/0001157523-23-000729.json","markdown":"https://secwatch.observer/filing/0001157523-23-000729.md","text":"https://secwatch.observer/filing/0001157523-23-000729.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896264/000115752323000729/0001157523-23-000729-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896264/000115752323000729/a53393393.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T23:49:30.345636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}